call for Late-breaking abstracts TO eular 2021
EULAR invites you to submit a late-breaking abstract to the European Congress of Rheumatology, EULAR 2021, to take place as a virtual Congress.
Clinical and scientific breakthroughs will be selected for late-breaking abstract presentations to participants of EULAR 2021, based on merit, timeliness and interest by the Scientific and Abstract Committees. The late-breaking research is limited to highly significant and timely findings in rheumatology that were not available by 31 January 2021 (the deadline of regular abstract submission).
Submit your late breaking abstract
Rules and regulations
The following specific rules and regulations apply to late-breaking abstract submission:
- Late-breaking abstract submission must be done under the dedicated submission track (late breaking abstract). To submit a late breaking abstract, a non-refundable processing fee of EUR 100 will be charged at the time of online submission. Authors of rejected, incomplete or wrongly submitted abstracts will not be refunded.
- Splitting of data originating from the same study across several abstracts and/or topics is not permitted and will lead to rejection of the abstracts.
- It is mandatory to use the abstract word template provided by the system. Please read all instructions carefully before preparing your abstract.
Counting towards the 3600 characters:
— Abstract title (minimum 15, maximum 300 characters)
— Headings and content of the abstract word template, structured into the following sections:
g. Characters from table content including title and footnotes.
Characters not counted, but part of final abstract:
— Author first names, middle initials and last names
— Author affiliations
— Acknowledgements including working group
— Working group + "on behalf of" if entered
— Abstract number
— DOI (Declaration of conflict of interest)
— Invisible characters such as spaces
Tables (characters included count): A maximum of one table can be included in the abstract word template with the following criteria: maximum number of columns: 12 / rows: 20
Graphs / Images: A maximum of one graph OR one image can be included. Multiple panel figures are not allowed. Tables turned into pictures/images are not accepted.
Late breaking abstracts can be re-edited and modiﬁed until the submission deadline (29 April 2021, 23:59 CEST). Please ensure that your late breaking abstract does not contain spelling, grammatical or scientiﬁc errors, as it will be reproduced exactly as submitted. No proofreading will be done.
Late breaking abstracts accepted for the congress are subject to the EULAR embargo rules. With the submission of a late breaking abstract the authors agree to the embargo rules.
Conﬂict of interest: It is the intent of EULAR to provide high quality sessions focused on educational content that is free from commercial inﬂuence or bias. Thus the submitting author of an abstract is requested to declare any potential conﬂicts of interest for all authors during the abstracts submission.
The presenting author can be any of the listed authors without affiliations to industry.
The inclusion of trade names/brand names is not allowed in the abstract. The mentioning of agents/molecules must follow the scientiﬁc standard for publications.
The corresponding author has the right to grant, and does grant, on behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.
Only late breaking abstracts that contain original data can be submitted.
Late breaking abstracts will be reviewed blinded. The reviewers will judge the late breaking abstracts according to the scientiﬁc or clinical value, relevance to EULAR, suitability of methods to aims, conclusions conﬁrmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
Late breaking abstract acceptance will be as oral presentation.
Should the late breaking abstract be selected for oral presentation, the authors, represented by the presenting author will be required to sign an agreement to grant EULAR the right to record the presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee). The full text of the agreement, the publication licence, can be found on the right side of the column.
Accepted late breaking abstracts will be published in a supplement to the Annals of Rheumatic Diseases (ARD). Information on accepted late breaking abstracts (title and authors) will be available online about two weeks prior to the congress. Published late breaking abstracts will be available in the EULAR Abstract Archive during and after the congress.
The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) in the session and the time assigned by the EULAR Congress Committee. We therefore recommend submitters of late breaking abstracts to register for the congress at the time of late breaking abstract submission.
Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit a late breaking abstract. The ﬁnal decision about acceptance of a late breaking abstract will be taken by the EULAR Scientiﬁc Programme Committee. EULAR does not communicate, nor enter into correspondence on the reasons for acceptance/rejection of an abstract.
Withdrawal of your late breaking abstract is not possible after final submission (29 April 2021 23:59 CEST).
Submission technical requirements
The internet abstract submission system works best with the most updated versions of Chrome or Firefox.
- Cookies need to be enabled
- All pop-up blockers should be turned off
Instructions for abstract presentations
If an abstract is selected for oral or poster presentation, the presenting author shall:
- As speciﬁed at submission, present in the assigned session. Details will be communicated to the presenting author.
- Sign an agreement in representation of all the abstract authors, to grant EULAR the right to record the entire presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee).
- If an abstract is accepted as a poster tour presentation, the presenting author will be requested to be available for discussion during the corresponding poster viewing session.
- For further information contact: firstname.lastname@example.org
For assistance in your abstract submission you may contact our Abstract Helpdesk at email@example.com